← Eichor
Study identifier: NCT06133283 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Endurance Exercise & Virtual Reality for Optimizing Cortical Excitability and Neuroplasticity in PD

Condition: Parkinson Disease  ·  Sponsor: The University of Texas Health Science Center at San Antonio

PhaseNA
Planned participants16
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

This study aims to determine the effects of aerobic exercise as a primer to add-on virtual reality (VR)-based rehabilitation on balance, postural control and neuroplasticity (ability of brain to adapt in structure and function) in individuals with Parkinson's disease (PD). This study will utilize two groups - one group will receive the exercise and VR, while the other group will receive stretching exercise and VR over eight weeks. The study team will administer outcomes at baseline, post-intervention (8 weeks) and follow-up (6 weeks after post-assessment).

This description comes directly from the study's public registry record.

Talk to the study team

Anjali Sivaramakrishnan, PhD  ·  210-567-8626  ·  sivaramakris@uthscsa.edu

Always discuss trial participation with your own doctor first.

Locations (1)

UT Health San Antonio- Dept. of Physical TherapySan Antonio, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06133283